Lifeline Scientific, Inc. (LSI.L) reported that its full-year 2011 net income attributable to co. increased to $3.47 million from $2.20 million last year. On a per share basis, earnings was $0.17 versus 0.12 year-ago.
For the twelve months, net income totaled $3.27 million compared to $1.99 million previous year.
Operating profit for the period decreased to $1.9 million from $4.5 million prior year reflecting planned strategic investments in product development and geographic expansion.
The company's total revenue advanced to $25.39 million from year ago's $23.17 million, primarily due to increased unit sales of LifePort Kidney Transporter and a significant increase in sales of solutions and consumable products.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org